Skip to main content

Table 4 Usefulness of the medication surveillance program in a clinical setting per total respondents: physicians and pharmacists

From: Physician and pharmacist satisfaction and clinical needs for the real-time medication surveillance program in South Korea

Medication surveillance program Frequency (%) p-value
Very un-useful Somewhat un-useful Neutral Somewhat useful Very useful
Drug–drug interaction 11 (1.0) 49 (4.4) 133 (12.0) 299 (26.9) 618 (55.7) < 0.001
 Physicians 10 (2.0) 34 (6.8) 64 (12.9) 161 (32.4) 228 (45.9)  
 Pharmacists 1 (0.2) 15 (2.4) 69 (11.3) 138 (22.5) 390 (63.6)  
Age contraindication: Pediatric, Elderly 20 (1.8) 59 (5.3) 226 (20.4) 361 (32.5) 444 (40.0) < 0.001
 Physicians 17 (3.4) 39 (7.8) 129 (26.0) 166 (33.4) 146 (29.4)  
 Pharmacists 3 (0.5) 20 (3.3) 97 (15.8) 195 (31.8) 298 (48.6)  
Pregnancy contraindication 28 (2.5) 58 (5.2) 198 (17.9) 295 (26.7) 526 (47.6) < 0.001
 Physicians 24 (4.9) 38 (7.7) 101 (20.4) 143 (28.9) 188 (38.1)  
 Pharmacists 4 (0.7) 20 (3.3) 97 (15.9) 152 (24.9) 338 (55.3)  
Therapeutic duplication 18 (1.6) 76 (6.9) 245 (22.2) 361 (32.6) 406 (36.7) < 0.001
 Physicians 17 (3.4) 45 (9.1) 131 (26.5) 172 (34.8) 129 (26.1)  
 Pharmacists 1 (0.2) 31 (5.1) 114 (18.6) 189 (30.9) 277 (45.3)  
  1. * p-value was calculated using chi-square test
\